The Effect of a Methylprednisolone Taper on Outcomes Following Total Knee Arthroplasty
Key facts
- Who runs it
- F. Johannes Plate
- Where
- Monroeville and Pittsburgh, United StatesSee the 2 sites
- Trial code
- Status
- Withdrawn
- Phase
- Phase 4
- Started
- 1 Nov 2025
- Expected to end
- 1 Dec 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Methylprednisolone 4 milligram Tab
- Dexamethasone injection
- Record updated
- 5 February 2026
- Why it stopped
- withdrawn
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Patients indicated for primary total knee arthroplasty
- Access to computer or smartphone for completion of REDCap surveys
Who cannot take part
- Patients less than 18 years of age, patients unable to consent, known diabetic patients and those with an HgbA1c >6.5 preoperatively, patients who are on chronic steroid treatments, patients with chronic pain on opioid management, patients with allergies to steroids, patients with a history of peptic ulcer disease, patients with a history of heart failure and patients with a history of renal and/or hepatic failure will be excluded. Those that are immunosuppressed as well as pregnant and/or lactating will also be excluded
Where in United States
- UPMC EastMonroeville, United States
- UPMC-Shadyside HospitalPittsburgh, United States
About the trial
What the trial wants to find out
Pain control and early range of motion following total knee arthroplasty are essential for patient satisfaction. Intraoperative steroids (dexamethasone) have been shown to have a significant effect in controlling acute pain following total knee arthroplasty. This study aims to evaluate the effect of a post-operative steroid (methylprednisolone) taper in improving functional and patient-reported outcomes following total knee arthroplasty. A taper means taking a high dose of a medication followed by taking lower doses and each following day until the medication is stopped.
The 2 groups in the trial
- Intraoperative and Post-operative steroidTreatment being tested
Patients in this groups will receive intraoperative intravenous dexamethasone as well as a 6-day post-operative methylprednisolone taper
Treatment: Methylprednisolone 4 milligram Tab and Dexamethasone injection
- Intraoperative SteroidExisting treatment, for comparison
Patients randomized to this group will only receive intraoperative intravenous dexamethasone
Treatment: Dexamethasone injection
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 5 February 2026